chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for covid19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid19) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 19-Jan-2021, the patient experienced COVID-19 (tested positive for covid19). At the time of the report, COVID-19 (tested positive for covid19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, COVID-19: (Positive) positive.         No treatment information and concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: second dose information
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (Reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction). At the time of the report, VACCINATION COMPLICATION (Reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test negative
Clinical narrative: Patient tested negative for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST NEGATIVE (Patient tested negative for COVID-19) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced SARS-COV-2 TEST NEGATIVE (Patient tested negative for COVID-19). At the time of the report, SARS-COV-2 TEST NEGATIVE (Patient tested negative for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, COVID-19: negative (Negative) nasal test negative. On 01-Feb-2021, COVID-19: negtive (Negative) saliva test negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment for the event was not reported.  Patient was tested negative for COVID-19 yet quarantined still.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection arm began to hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Injection arm began to hurt) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included Tendonitis. Concomitant products included HYDROCHLOROTHIAZIDE and POTASSIUM (POTASSIUM pills) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Injection arm began to hurt). At the time of the report, PAIN IN EXTREMITY (Injection arm began to hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that the patient had lingering arm pain and she could not reach behind her without pain. She would decide after seeing her doctor if the pain was from vaccine or from tendonitis unrelated to the vaccine. The patient took Ibuprofen to lessen the pain.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: current condition added
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin reaction, Vaccination site erythema, Vaccination site rash
Clinical narrative: delayed cutaneous hypersensitivity (COVID arm). Ater first vaccine only.; indurated and was very itchy; A red area reaction around the site of injection.; rash with sharp boundaries; This spontaneous case was reported by a physician and describes the occurrence of SKIN REACTION (delayed cutaneous hypersensitivity (COVID arm). Ater first vaccine only.), PRURITUS (indurated and was very itchy), VACCINATION SITE ERYTHEMA (A red area reaction around the site of injection.) and VACCINATION SITE RASH (rash with sharp boundaries) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa, omeprazole). Concomitant products included DULOXETINE for Depression, DENOSUMAB (PROLIA) for Osteopenia, GABAPENTIN for Peripheral neuropathy, FAMOTIDINE for Reflux gastritis, CALCIUM, VITAMIN D NOS, MAGNESIUM and ASA.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On 14-Jan-2021, the patient experienced PRURITUS (indurated and was very itchy), VACCINATION SITE ERYTHEMA (A red area reaction around the site of injection.) and VACCINATION SITE RASH (rash with sharp boundaries). On 20-Jan-2021, the patient experienced SKIN REACTION (delayed cutaneous hypersensitivity (COVID arm). Ater first vaccine only.). At the time of the report, SKIN REACTION (delayed cutaneous hypersensitivity (COVID arm). Ater first vaccine only.), PRURITUS (indurated and was very itchy) and VACCINATION SITE ERYTHEMA (A red area reaction around the site of injection.) had resolved and VACCINATION SITE RASH (rash with sharp boundaries) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered SKIN REACTION (delayed cutaneous hypersensitivity (COVID arm). Ater first vaccine only.) to be related. No further causality assessments were provided for PRURITUS (indurated and was very itchy), VACCINATION SITE ERYTHEMA (A red area reaction around the site of injection.) and VACCINATION SITE RASH (rash with sharp boundaries).    Treatment include hydrocortisone cream.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up information included concomitant medications and outcome of events.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Dizziness, Nausea
Clinical narrative: POTS; Bad chills; nausea; diarrhea; general weakness; severe neck pain; dizziness; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (diarrhea), ASTHENIA (general weakness), NECK PAIN (severe neck pain), DIZZINESS (dizziness) and POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included GERD in 2010. Concurrent medical conditions included Seasonal allergy since 2010. Concomitant products included LORATADINE for Seasonal allergy.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced NECK PAIN (severe neck pain) and DIZZINESS (dizziness). On 08-Jan-2021, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (general weakness), CHILLS (Bad chills) and NAUSEA (nausea). On an unknown date, the patient experienced POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS). On 18-Jan-2021, DIARRHOEA (diarrhea), NECK PAIN (severe neck pain), DIZZINESS (dizziness), CHILLS (Bad chills) and NAUSEA (nausea) had resolved. At the time of the report, ASTHENIA (general weakness) had not resolved and POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2021: Case is non serious On 19-Mar-2021: Adding completed ADR form received from patient
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Postural orthostatic tachycardia syndrome
Clinical narrative: POTS; Bad chills; nausea; diarrhea; general weakness; severe neck pain; dizziness; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (diarrhea), ASTHENIA (general weakness), NECK PAIN (severe neck pain), DIZZINESS (dizziness) and POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included GERD in 2010. Concurrent medical conditions included Seasonal allergy since 2010. Concomitant products included LORATADINE for Seasonal allergy.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced NECK PAIN (severe neck pain) and DIZZINESS (dizziness). On 08-Jan-2021, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (general weakness), CHILLS (Bad chills) and NAUSEA (nausea). On an unknown date, the patient experienced POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS). On 18-Jan-2021, DIARRHOEA (diarrhea), NECK PAIN (severe neck pain), DIZZINESS (dizziness), CHILLS (Bad chills) and NAUSEA (nausea) had resolved. At the time of the report, ASTHENIA (general weakness) had not resolved and POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2021: Case is non serious On 19-Mar-2021: Adding completed ADR form received from patient
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache
Clinical narrative: extremely fatigued; Headaches; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extremely fatigued), HEADACHE (Headaches) and ARTHRALGIA (Joint pain) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (extremely fatigued), HEADACHE (Headaches) and ARTHRALGIA (Joint pain). At the time of the report, FATIGUE (extremely fatigued), HEADACHE (Headaches) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Swelling
Clinical narrative: swelling; redness at injection site; a lot of pain at injection site; A spontaneous report was received from a consumer concerning 30 years old, Female patient who experienced side effects of swelling, erythema at injection site and a lot of pain..   On 25-Jan-2021 the patient received the first dose of two planned doses of mRNA-1273 Vaccine, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  Patient received vaccine in left arm shoulder deltoid muscle  10 days after receiving the vaccination the patient experienced side effects of swelling, erythema and a lot of pain at injection site on 04-FEB-2021  Concomitant product use was not provided by the reporter.     Treatment information was not provided.   The Patient is fine now, the side effects resolved in 48 hours.  The outcome of the events was resolved/recovered.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site warmth
Clinical narrative: Experienced flu like symptoms; Warm touch at the injection site; Knot at the injection site; Sore at the injection site; Red Knot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Experienced flu like symptoms), VACCINATION SITE WARMTH (Warm touch at the injection site), VACCINATION SITE INDURATION (Knot at the injection site), VACCINATION SITE PAIN (Sore at the injection site) and VACCINATION SITE ERYTHEMA (Red Knot at the injection site) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Experienced flu like symptoms), VACCINATION SITE WARMTH (Warm touch at the injection site), VACCINATION SITE INDURATION (Knot at the injection site), VACCINATION SITE PAIN (Sore at the injection site) and VACCINATION SITE ERYTHEMA (Red Knot at the injection site). At the time of the report, INFLUENZA LIKE ILLNESS (Experienced flu like symptoms), VACCINATION SITE WARMTH (Warm touch at the injection site), VACCINATION SITE INDURATION (Knot at the injection site), VACCINATION SITE PAIN (Sore at the injection site) and VACCINATION SITE ERYTHEMA (Red Knot at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Tylenol and Benadryl as corrective treatment and mentioned that symptoms were ongoing.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: patient's first name corrected, email updated
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Redness at the injection arm; Swelling that is getting bigger at the injection arm; Hardness at the injection site; A spontaneous report was received from a consumer concerning a female patient who received Modern's COVID-19 vaccine (mRNA-1273) and experienced Pain in arm, Redness, headache.     The patient's medical history was vocal cord dysfunction, asthma and allergies. Concomitant medication albuterol were reported.     28-Dec-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection.     On 25-Jan-2021, The patient experienced swelling, redness and hardness at the injection site, that isgetting bigger. No Laboratory details provided.  The patient was given Benadryl  for the symptoms.     Action taken with mRNA-1273 in response to the events was fatigue, chills, headache, muscle aches and pains, other pain  reported.   At the time of this report, the outcome of the events injection site erythema, injection site rash, injection site inflammation is known.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Vertigo.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  Treatment of events was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up with patient: Patient was reported as confused and denied he reported adverse event to vaccine.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site swelling
Clinical narrative: itching; Swelling at the injection site; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching) and VACCINATION SITE SWELLING (Swelling at the injection site) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PRURITUS (itching) and VACCINATION SITE SWELLING (Swelling at the injection site). On 25-Jan-2021, PRURITUS (itching) had resolved. At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  Patient received vaccine on 13 Jan 2021 on right arm between his elbow and shoulder. He saw the doctor, who gave him a steroid for the reaction and some form of penicillin, but he doesn't think it's penicillin. He was still currently taking them up until today 25 Jan 2021. Within 30-45 minutes of taking both on 23 Jan 2021, the itching stopped and the swelling started to reduce a bit.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: NNI
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain in extremity, Vaccination site erythema
Clinical narrative: Diarrhea; Sore arm; a big red circle on the injection site; A spontaneous report was received from a consumer concerning a female patient who received Modern's COVID-19 vaccine (mRNA-1273) and experienced diarrhea, sore arm and a big red circle on the injection site.    The patient's medical history was not provided. No relevant concomitant medications were reported.      On 19 JAN 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029620) for prophylaxis of COVID-19 infection.    On 28 JAN 2021, The patient experienced diarrhea, sore arm and a big red circle on the injection site. No Laboratory details provided.    No treatment information was provided.     Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of the events diarrhea, sore arm and a big red circle on the injection site was Unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth, Peripheral swelling
Clinical narrative: injection site warm; slightly red; injection site itchiness; swelling arm; my arm hurt; A spontaneous report was received from a 60 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced peripheral swelling (swelling arm), injection site warmth (injection site warm), injection site pruritus (injection site itchiness), injection site pain (my arm hurt), and injection site erythema (slightly red).  The patient's medical history was not provided. The concomitant medications included amlodipine besylate.  On 12-Jan-2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 041L20A) intramuscularly for prophylaxis of COVID-19 infection. On 13-Jan-2021, a day after receiving the first dose of the vaccine, the patient experienced pain and swelling in the arm. On 18-Jan-2021, the patient had experienced itching. On 19-Jan-2021, it was known that the patient's arm had swelled up again, was red and tender, and hot to touch. On 22-Jan-2021, the redness in arm had decreased although feeling of warmth on touch was persisting. On 26-Jan-2021, slight redness was observed in the arm without any swelling and warmth on touch, though little itchiness was still persisting at the time of the report.  Treatment information included application of ice packs, and hydrocortisone cream.  Action taken with mRNA-1273 was unknown.  The outcome of the events, peripheral swelling (swelling arm), injection site warmth (injection site warm), injection site pain (my arm hurt), was considered as recovered/resolved and for the events injection site pruritus (injection site itchiness), injection site erythema (slightly red), was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: delayed reaction; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (delayed reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (delayed reaction). At the time of the report, VACCINATION COMPLICATION (delayed reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Additional information received - consumer provided her email.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hot to the touch; red; itchy; arm got swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE WARMTH (hot to the touch) and VACCINATION SITE SWELLING (arm got swollen) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure (Patient is taking medicines for Blood Pressure.), Cholesterol (Patient is taking medicines for cholesterol.) and Kidney stone (Patient is taking medicines for Kidney Stone.).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE WARMTH (hot to the touch) and VACCINATION SITE SWELLING (arm got swollen). At the time of the report, VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE WARMTH (hot to the touch) and VACCINATION SITE SWELLING (arm got swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Abnormal tingling on left side of face; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Abnormal tingling on left side of face) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced PARAESTHESIA (Abnormal tingling on left side of face). At the time of the report, PARAESTHESIA (Abnormal tingling on left side of face) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain
Clinical narrative: Hard time lifting up arm; Soreness on arm above injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Hard time lifting up arm) and VACCINATION SITE PAIN (Soreness on arm above injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025620A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 26-Jan-2021 at 5:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Hard time lifting up arm) and VACCINATION SITE PAIN (Soreness on arm above injection site). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Hard time lifting up arm) and VACCINATION SITE PAIN (Soreness on arm above injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included blood pressure medication NOS. Treatment included acetaminophen.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: adverse reaction; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION COMPLICATION (adverse reaction) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041LZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reaction). At the time of the report, VACCINATION COMPLICATION (adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Periorbital swelling, Pruritus, Urticaria
Clinical narrative: Itchy; hives on neck and chest; shortness of breath; chest pain; eyes puffed out really bad; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), URTICARIA (hives on neck and chest), PERIORBITAL SWELLING (eyes puffed out really bad), DYSPNOEA (shortness of breath) and CHEST PAIN (chest pain) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (the patient was allergic to sulfa). Concomitant products included ESCITALOPRAM and ARIPIPRAZOLE for an unknown indication.    On 21-Jan-2021 at 10:12 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PERIORBITAL SWELLING (eyes puffed out really bad). On an unknown date, the patient experienced PRURITUS (Itchy), URTICARIA (hives on neck and chest), DYSPNOEA (shortness of breath) and CHEST PAIN (chest pain). The patient was treated with PREDNISONE ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, PRURITUS (Itchy), URTICARIA (hives on neck and chest), PERIORBITAL SWELLING (eyes puffed out really bad), DYSPNOEA (shortness of breath) and CHEST PAIN (chest pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Nausea, Vaccination site mass, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Redness/erythema; Nausea/ vomiting; vomiting; Vaccination site swelling; Vaccination site mass; Vccination site warmth; Vccination site rash; Vaccination site pruritus/ itching/ Redness/ small bumps; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness/erythema), NAUSEA (Nausea/ vomiting) and VOMITING (vomiting) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism since 1987, Dry eye, Osteopenia (Bone disease.), Urticaria, Neuropathy since 2014, Arthritis since 2010, Acid reflux (esophageal) since 2010, Allergy to antibiotic (Hives), Tetanus (Hives) and Penicillin allergy (Hives). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Cholesterol, HYPROMELLOSE (RETAINE HPMC) and SODIUM CHLORIDE (MURO 128) for Dry eye, CICLOSPORIN (RESTASIS MULTIDOSE) for Dry eyes, FAMOTIDINE (PEPCID AC) for GERD, LEVOTHYROXINE for Hypothyroidism, MARIJUANA for Insomnia, GABAPENTIN for Neuropathy, IBANDRONATE SODIUM and CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]) for Osteopenia, VITAMIN D3 for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness/erythema), NAUSEA (Nausea/ vomiting) and VOMITING (vomiting). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) ongoing since an unknown date for Itching, at a dose of 1 dosage form. At the time of the report, ERYTHEMA (Redness/erythema), NAUSEA (Nausea/ vomiting) and VOMITING (vomiting) had resolved.            Antihistamines were used as treatment for event. Events-itching, redness, bumps subsided after 1-2 weeks of after  1st shot Patient went to doctor office/urgent care visit after the events to seek medical care Itching was still going on in left arm as of 28-jun-2021 Action taken with mRNA-1273 with response to event was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-up information received on 28-JUN-2021: Updated Patient demographics, Medical history, Con meds, Treatment, Events were added.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth, Vomiting
Clinical narrative: Redness/erythema; Nausea/ vomiting; vomiting; Vaccination site swelling; Vaccination site mass; Vccination site warmth; Vccination site rash; Vaccination site pruritus/ itching/ Redness/ small bumps; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness/erythema), NAUSEA (Nausea/ vomiting) and VOMITING (vomiting) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism since 1987, Dry eye, Osteopenia (Bone disease.), Urticaria, Neuropathy since 2014, Arthritis since 2010, Acid reflux (esophageal) since 2010, Allergy to antibiotic (Hives), Tetanus (Hives) and Penicillin allergy (Hives). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Cholesterol, HYPROMELLOSE (RETAINE HPMC) and SODIUM CHLORIDE (MURO 128) for Dry eye, CICLOSPORIN (RESTASIS MULTIDOSE) for Dry eyes, FAMOTIDINE (PEPCID AC) for GERD, LEVOTHYROXINE for Hypothyroidism, MARIJUANA for Insomnia, GABAPENTIN for Neuropathy, IBANDRONATE SODIUM and CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]) for Osteopenia, VITAMIN D3 for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness/erythema), NAUSEA (Nausea/ vomiting) and VOMITING (vomiting). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) ongoing since an unknown date for Itching, at a dose of 1 dosage form. At the time of the report, ERYTHEMA (Redness/erythema), NAUSEA (Nausea/ vomiting) and VOMITING (vomiting) had resolved.            Antihistamines were used as treatment for event. Events-itching, redness, bumps subsided after 1-2 weeks of after  1st shot Patient went to doctor office/urgent care visit after the events to seek medical care Itching was still going on in left arm as of 28-jun-2021 Action taken with mRNA-1273 with response to event was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-up information received on 28-JUN-2021: Updated Patient demographics, Medical history, Con meds, Treatment, Events were added.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the site of injection) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for Covid-19 Vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness at the site of injection). At the time of the report, VACCINATION SITE PAIN (soreness at the site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warm to touch at vaccination site; vaccination site redness; vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (vaccination site redness), VACCINATION SITE PRURITUS (vaccination site pruritus) and VACCINATION SITE WARMTH (warm to touch at vaccination site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), LISINOPRIL, BUPROPION, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), ASCORBIC ACID, RETINOL, TOCOPHEROL (OCUVITE [ASCORBIC ACID;RETINOL;TOCOPHEROL]), MULTIVITAMIN [VITAMINS NOS] and SIMVASTATIN for an unknown indication, COLECALCIFEROL, MENAQUINONE-7, PHYTOMENADIONE, RETINOL PALMITATE, TOCOPHEROL, TOCOTRIENOLS NOS (VITAMIN D COMPLEX).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (vaccination site redness), VACCINATION SITE PRURITUS (vaccination site pruritus) and VACCINATION SITE WARMTH (warm to touch at vaccination site). At the time of the report, VACCINATION SITE ERYTHEMA (vaccination site redness), VACCINATION SITE PRURITUS (vaccination site pruritus) and VACCINATION SITE WARMTH (warm to touch at vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: very high pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very high pain in her arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer. Concomitant products included LETROZOLE for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (very high pain in her arm). The patient was treated with NAPROXEN SODIUM (ALEVE) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (very high pain in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021:  follow up Received on 05-JUL-2021 containing No newInformation
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Skin reaction
Clinical narrative: Delayed injection site reaction; Injection site itchy; Injection site red; Injection site swelling; This spontaneous case was reported by a physician and describes the occurrence of SKIN REACTION (Delayed injection site reaction), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swelling) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20-2a) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced SKIN REACTION (Delayed injection site reaction), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swelling). At the time of the report, SKIN REACTION (Delayed injection site reaction), INJECTION SITE PRURITUS (Injection site itchy), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm; A spontaneous report was received from a consumer (patient), concerning a 67-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm (pain in arm).  The patient's medical history was not provided.  Concomitant medications included omeprazole, fluoxetine hydrochloride, propranolol, colestipol, acetylsalicylic acid, and calcium.  On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: 037K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 28 Dec 2020, following the first vaccination, the patient experienced sore arm for a couple of days.  Treatment information for the event was not provided.  There was no change planned to the dosing schedule of mRNA-1273 in response to the event.  The outcome of the event of sore arm (pain in arm) was resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: A little warm; Dizzy; Off balance; Swollen and raised; It was red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (A little warm), DIZZINESS (Dizzy), BALANCE DISORDER (Off balance), VACCINATION SITE SWELLING (Swollen and raised) and VACCINATION SITE ERYTHEMA (It was red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012LZCA) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX), METOPROLOL, LOVASTATIN, MONTELUKAST SODIUM (SINGULAIR), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), LINACLOTIDE (LINZESS), VITAMIN D NOS, AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE (DYMISTA) and TIMOLOL MALEATE (TIMOPTIC) for an unknown indication.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swollen and raised) and VACCINATION SITE ERYTHEMA (It was red). On 24-Jan-2021, the patient experienced DIZZINESS (Dizzy) and BALANCE DISORDER (Off balance). On 26-Jan-2021, the patient experienced VACCINATION SITE WARMTH (A little warm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (A little warm) and VACCINATION SITE SWELLING (Swollen and raised) had not resolved and DIZZINESS (Dizzy), BALANCE DISORDER (Off balance) and VACCINATION SITE ERYTHEMA (It was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site pruritus
Clinical narrative: Redness; Vaccination site Itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Vaccination site Itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Vaccination site Itchy). At the time of the report, ERYTHEMA (Redness) outcome was unknown and VACCINATION SITE PRURITUS (Vaccination site Itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site was sore) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site was sore). At the time of the report, VACCINATION SITE PAIN (injection site was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Anxiety, Fatigue, Hypotension
Clinical narrative: Agitated; low blood pressure; anxious and jittery; fatigued, didn't want to get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of AGITATION (Agitated), HYPOTENSION (low blood pressure), ANXIETY (anxious and jittery) and FATIGUE (fatigued, didn't want to get out of bed) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AGITATION (Agitated), HYPOTENSION (low blood pressure), ANXIETY (anxious and jittery) and FATIGUE (fatigued, didn't want to get out of bed). At the time of the report, AGITATION (Agitated), HYPOTENSION (low blood pressure), ANXIETY (anxious and jittery) and FATIGUE (fatigued, didn't want to get out of bed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: low grade fever; fatigue; mild body aches; swelling at the injection site; redness at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (low grade fever), FATIGUE (fatigue), MYALGIA (mild body aches), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, LISINOPRIL, METFORMIN, LIRAGLUTIDE (VICTOZA), ATORVASTATIN, FUROSEMIDE, FAMOTIDINE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced PYREXIA (low grade fever), FATIGUE (fatigue), MYALGIA (mild body aches), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 10-Jan-2021, VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) had resolved. At the time of the report, PYREXIA (low grade fever), FATIGUE (fatigue) and MYALGIA (mild body aches) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-013466 (Patient Link).